Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,203,755
-
Share change
-
+189,177
-
Total reported value
-
$1,677,525,286
-
Put/Call ratio
-
11%
-
Price per share
-
$118.11
-
Number of holders
-
87
-
Value change
-
+$26,820,727
-
Number of buys
-
48
-
Number of sells
-
44
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q4 2020
As of 31 Dec 2020,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,203,755 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., Temasek Holdings (Private) Ltd, Pentwater Capital Management LP, BANK OF AMERICA CORP /DE/, CAPSTONE INVESTMENT ADVISORS, LLC, VANGUARD GROUP INC, Maso Capital Partners Ltd, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, and ALPINE ASSOCIATES MANAGEMENT INC..
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.